https://www.selleckchem.com/pr....oducts/cucurbitacin-
support the benefits of tezepelumab in patients with severe, uncontrolled asthma. Little is known about the practice of ventilation management in patients with COVID-19. We aimed to describe the practice of ventilation management and to establish outcomes in invasively ventilated patients with COVID-19 in a single country during the first month of the outbreak. PRoVENT-COVID is a national, multicentre, retrospective observational study done at 18 intensive care units (ICUs) in the Netherlands. Consecutive patients aged at least 1
Like
Comment
Share
